Understanding Competition in U.S. Prescription Drug Markets: Entry and Supply Chain Dynamics #00487

Submission Number:
00487
Commenter:
Tiffany McCaslin
Organization:
National Business Group on Health
State:
District of Columbia
Initiative Name:
Understanding Competition in U.S. Prescription Drug Markets: Entry and Supply Chain Dynamics
Dear Sir or Madam: Attached, please find our comments for the November 8 workshop: Understanding Competition in Prescription Drug Markets: Entry and Supply Chain Dynamics. Respectfully, Tiffany Tiffany L. McCaslin Senior Policy Analyst, Public Policy National Business Group on Health 20 F Street, NW ? Suite 200 ? Washington, DC 20001-6705 Phone: 202-558-3013 ? Fax: 202-628-9244 ?mccaslin@businessgrouphealth.org Creative Health Benefits Solutions for Today, Strong Policy for Tomorrow